Coronavirus Pandemic Update 37: The ACE-2 Receptor - The Doorway to COVID-19 (ACE Inhibitors & ARBs)

Coronavirus (COVID-19) Update 37 with pulmonologist Roger Seheult, MD of The ACE-2 receptor on our cells is the binding site for SARS-CoV-2, the virus that causes COVID-19. As a result, the ACE-2 receptor is central to many important questions about coronavirus treatment, a COVID-19 vaccine, and should patients continue taking their ACE inhibitor / ARBs (Angiotensin II Receptor Blockers) medications. Dr. Seheult discusses the controversy about some of these questions and illustrate